# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Idiopathic myopathy

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 1-10 of 14 results.
Optimizing Treatment on Idiopathic Inflammatory Myopathies
Status: Recruiting
Last Changed: Apr 22, 2019
First Received: Mar 27, 2017
Disease(s): Idiopathic Inflammatory Myopathies
Intervention(s): Intravenous Infusion
Locations: Samuel Katsuyuki Shinjo, Sao Paulo, Brazil
Application of Electrical Impedance Myography (EIM) as a Potential Biomarker of Idiopathic Inflammatory Myopathies
Status: Not yet recruiting
Last Changed: Apr 19, 2019
First Received: Apr 17, 2019
Disease(s): Idiopathic Inflammatory Myopathies
Intervention(s): electrical impedance myography, healthy control group
Elastography in Patients With Idiopathic Inflammatory Myopathies
Status: Recruiting
Last Changed: Jan 06, 2020
First Received: Apr 01, 2019
Disease(s): Idiopathic Inflammatory Myopathies
Intervention(s): strain elastography
Locations: Benha University Hospital, Banhā, Qalubiya, Egypt
Physical Training in Patients With Idiopathic Inflammatory Myopathies
Status: Recruiting
Last Changed: Nov 19, 2018
First Received: Mar 27, 2017
Disease(s): Idiopathic Inflammatory Myopathies, Physical Activity
Intervention(s): Physical exercises
Locations: Samuel Katsuyuki Shinjo, Sao Paulo, Brazil
Treating Idiopathic Inflammatory Myopathies Related Reduced Bone Mineral Density With Denosumab or Zoledronic Acid
Status: Not yet recruiting
Last Changed: Jul 26, 2019
First Received: Jul 26, 2019
Disease(s): Idiopathic Inflammatory Myopathies, Osteoporosis, Osteopenia
Intervention(s): Denosumab, Zoledronic Acid
Locations: Kwong Wah Hospital, Hong Kong, Hong Kong
A Phase IIa Trial of the Oral JAK 1/2 Inhibitor, Baricitinib, in the Treatment of Adult IIM
Status: Not yet recruiting
Last Changed: Dec 23, 2019
First Received: Dec 23, 2019
Disease(s): Idiopathic Inflammatory Myopathies
Intervention(s): Baricitinib, Baricitinib
Low-dose Interleukin-2 Treatment on Idiopathic Inflammatory Myopathy
Status: Not yet recruiting
Last Changed: Aug 28, 2019
First Received: Aug 20, 2019
Disease(s): Inflammatory Myopathy
Intervention(s): Interleukin-2
Low-dose Interleukin-2 in Combination With Standard Therapy on Idiopathic Inflammatory Myopathy
Status: Not yet recruiting
Last Changed: Jan 23, 2020
First Received: Jan 23, 2020
Disease(s): Inflammatory Myopathy
Intervention(s): Interleukin-2, ciclosporin and corticosteroid
MYOPROSP - a Prospective Cohort Study in Myositis
Status: Recruiting
Last Changed: Sep 26, 2019
First Received: Jun 11, 2015
Disease(s): Myositis, Idiopathic Inflammatory Myopathy
Locations: The University of Manchester, Manchester, Please Select, United Kingdom
Trial to Evaluate the Efficacy and Safety of Abatacept in Combination With Standard Therapy Compared to Standard Therapy Alone in Improving Disease Activity in Adults With Active Idiopathic Inflammatory Myopathy
Status: Recruiting
Last Changed: Aug 09, 2019
First Received: Nov 23, 2016
Disease(s): Polymyositis, Dermatomyositis, Autoimmune Necrotizing Myopathy, Overlap Myositis, Juvenile Myositis Above the Age of 18
Intervention(s): Abatacept subcutaneous, Placebo
Locations: Local Institution, Phoenix, Arizona, United States
Neuromuscular Research Center, Phoenix, Arizona, United States
Attune Health Research, Inc, Beverly Hills, California, United States
Local Institution, Fullerton, California, United States
University Of California Los Angeles, Los Angeles, California, United States
... and 94 other locations.